Harrow Health, Inc. (HROW) vs MannKind Corporation (MNKD)

A side-by-side comparison of Harrow Health, Inc. and MannKind Corporation across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — HROW vs MNKD

growth of $100 · dividends reinvested · last 10y
HROW +761.4% (+24.0%/yr)MNKD +21.5% (+2.0%/yr)HROW compounded faster over this window
Log scale — wide-divergence pair
101001k10kStart $10020182020202220242026$861$121
HROW MNKD

HROW vs MNKD: by the numbers

  • •MNKD is the larger company ($1.21B vs $1.14B market cap).
  • •Both run net losses; MNKD's is the smaller (-11.08% vs -13.51% net margin).
  • •MNKD grew revenue faster over the past five years (39.51% vs 34.52% CAGR).

Metrics side by side

Valuation

MetricHROWMNKD
P/S ratio4.143.07
P/B ratio75.02N/A
EV / EBITDAN/A52.09
FCF yield0.46%N/A

Profitability

MetricHROWMNKD
Gross margin73.28%75.69%
Operating margin14.18%11.12%
Net margin-13.51%-11.08%
ROE-244.91%N/A
ROIC1.81%1.32%

Growth (annualized)

MetricHROWMNKD
Revenue CAGR (5Y)34.52%39.51%
Total return CAGR (5Y)27.66%-4.18%

Frequently asked

Which has grown faster, HROW or MNKD?
Over the past five years, MNKD grew revenue faster — HROW at a 34.52% CAGR versus MNKD at 39.51%.
How have HROW and MNKD total returns compared?
Over the past 10 years, HROW delivered 23.49% and MNKD delivered 1.97% annualized total return. Past performance doesn't predict future results.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.